YOLFTbeta
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.

300937 · SHE · Healthcare / Pharmaceutical Retailers

20.53CNY-0.81 (-3.80%)

Price History

Full chart

Market Stats

Previous Close21.34
Open21.45
Day Range20.50 – 21.59
52-Week Range18.52 – 44.38
Volume1.97M
Market Cap2.30B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.14
Dividend Yield0.00%
Beta0.03
50-Day Avg25.35
200-Day Avg28.15

About

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. provides omni-channel pharmaceutical distribution services in China. It offers pharmaceutical products, such as Western medicine, traditional Chinese medicine preparations, Chinese herbal medicine pieces and raw materials, food and health food, medical devices; and non-pharmaceutical products and others. The company also provides clinics, E-commerce platform operation, logistics and distribution, management consulting, warehousing, cultural and artistic exchange, drug sale and retail chain, technology promotion and application, internet hospital, other organizational management, new media operation, equipment sales, and software development services, and information technology services, as well as engages in medical research and experimental development, and online pharmaceutical retail businesses. The company was founded in 2007 and is based in Chengdu, China.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Shunjun Chen
  • Employees1.04K
  • HeadquartersNo. 18, Youlian 1st Street, Chengdu, China, 610081, China
  • Websitehttps://www.hezongyy.com

Leadership

  • Mr. Shunjun ChenChairman & GM · b. 1977
  • Mr. De Qiang ZhengDeputy GM & Financial Director · b. 1984
  • Ms. Mingyi WangDeputy GM & Board Secretary · b. 1984
  • Fei WenAccounting Supervisor

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.29B2.79B3.40B3.97B4.43B4.39B4.45B
Growth (%)-+21.87%+21.88%+16.72%+11.62%-0.81%+1.35%
Cost of Revenue2.08B2.59B3.21B3.65B4.06B4.00B3.99B
Gross Profit208.51M198.30M185.77M315.42M367.60M392.67M463.91M
Gross Margin9.11%7.11%5.46%7.95%8.30%8.94%10.42%
Operating Expense126.10M128.22M175.23M236.55M271.24M350.68M419.66M
Operating Income82.41M70.08M10.53M78.88M96.36M41.99M44.25M
Operating Margin3.60%2.51%0.31%1.99%2.17%0.96%0.99%
EBITDA89.71M73.69M26.52M75.17M102.88M53.19M46.19M
EBITDA Margin3.92%2.64%0.78%1.89%2.32%1.21%1.04%
Net Income64.66M54.02M6.40M42.02M59.53M13.20M-12.85M
Net Income Margin2.82%1.94%0.19%1.06%1.34%0.30%-0.29%
R&D--11.38M17.71M19.32M15.47M10.72M
R&D as % of Total Revenue--0.33%0.45%0.44%0.35%0.24%
Interest Expense6.42M1.82M1.82M6.42M6.58M9.71M9.09M
Interest Expense % of Total Revenue0.28%0.07%0.05%0.16%0.15%0.22%0.20%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets743.64M844.65M1.19B1.59B1.69B1.70B1.72B
Total Liabilities256.54M319.42M399.13M771.64M831.02M866.22M923.95M
Total Equity475.78M518.02M773.51M813.94M854.22M843.23M820.81M
Cash123.17M114.23M153.78M457.82M374.86M386.88M409.36M

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow42.33M69.32M-154.38M152.67M-115.47M124.43M-13.23M
Capital Expenditure36.45M35.22M31.43M18.32M35.33M32.41M7.57M
Free Cash Flow5.89M34.10M-185.81M134.35M-150.80M92.02M-20.80M
Dividends Paid1.94M12.64M20.67M5.31M24.12M30.25M17.76M
FCF to OCF13.91%49.19%120.36%88.00%130.59%73.96%157.25%
Dividend Paid to FCF32.87%37.08%-11.12%3.95%-15.99%32.87%-85.40%

Earnings

Report DateMar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------
EPS Actual0.010.080.02-0.050.10-0.020.100.260.330.160.040.100.100.030.020.030.04-0.12-0.01-0.05-0.03-0.07
Surprise----------------------
Timing----------------------

Key Statistics & Ratios

Market Cap2.30B
Enterprise Value2.13B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.51
Price / Book2.89
EPS-0.14
Book Value8.48
Revenue (TTM)4.47B
Gross Profit (TTM)425.87M
EBITDA27.10M
Profit Margin-0.29%
Operating Margin-1.50%
Return on Equity-2.15%
Return on Assets0.31%
Shares Outstanding95.67M
Shares Float43.21M
Beta0.03
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
0.10Jun 13, 2025
20241×
0.22Jun 13, 2024
20231×
0.20May 22, 2023
20211×
0.20May 21, 2021